IL-21 enhances dendritic cell ability to induce interferon-γ production by natural killer T cells

Immunobiology

Volumn 212, Issue 7, 2007, Pages 537-547

  Maeda, Masanori ^a,b   Yanagawa, Yoshiki ^a   Iwabuchi, Kazuya ^a   Minami, Keita ^b   Nakamaru, Yuji ^b   Takagi, Dai ^b   Fukuda, Satoshi ^b   Onoé, Kazunori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine production; Dendritic cells; IFN ; IL 21; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 21; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; LEUKOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 34547156550     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.03.007     Document Type: Article

References (57)

1. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van D.T., and Pulendran B. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171 (2003) 4984-4989
2. Arase H., Arase N., Ogasawara K., Good R.A., and Onoé K. An NK1.1+CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc. Natl. Acad. Sci. USA 89 (1992) 6506-6510
3. Arase H., Arase N., Nakagawa K., Good R.A., and Onoé K. NK1.1+CD4+CD8- thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23 (1993) 307-310
4. Arase H., Arase N., Kobayashi Y., Nishimura Y., Yonehara S., and Onoé K. Cytotoxicity of fresh NK1.1+ T cell receptor α/β+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J. Exp. Med. 180 (1994) 423-432
5. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
6. Brady J., Hayakawa Y., Smyth M.J., and Nutt S.L. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172 (2004) 2048-2058
7. Brandt K., Bulfone-Paus S., Foster D.C., and Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102 (2003) 4090-4098
8. Brasel K., De Smedt T., Smith J.L., and Maliszewski C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96 (2000) 3029-3039
9. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.Y., Pestel J., and Jeannin P. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167 (2001) 3682-3686
10. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., and Mackay C.R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173 (2004) 68-78
11. Di Carlo E.D., Comes A., Orengo A.M., Rosso O., Meazza R., Musiani P., Colombo M.P., and Ferrini S. IL-21 induces tumor rejection by specific CTL and IFN-γ-dependent CXC chemokines in syngeneic mice. J. Immunol. 172 (2004) 1540-1547
12. Dillon S., Agrawal A., Dyke T.V., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., and Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172 (2004) 4733-4743
13. Finkelman F.D., Madden K.B., Morris S.C., Holmes J.M., Boiani N., Katona I.M., and Maliszewski C.R. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151 (1993) 1235-1244
14. Fujii S., Shimizu K., Kronenberg M., and Steinman R.M. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat. Immunol. 3 (2002) 867-874
15. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today 21 (2000) 573-583
16. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90 (1997) 3245-3287
17. Hayakawa Y., Takeda K., Yagita H., Kakuta S., Iwakura Y., Van Kaer L., Saiki I., and Okumura K. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31 (2001) 1720-1727
18. Illés Z., Kondo T., Newcombe J., Oka N., Tabira T., and Yamamura T. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164 (2000) 4375-4381
19. Inaba K., Turley S., Iyoda T., Yamaide F., Shimoyama S., Reis e Sousa C., Germain R.N., Mellman I., and Steinman R.M. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191 (2000) 927-936
20. Iwabuchi K., Iwabuchi C., Tone S., Itoh D., Tosa N., Negishi I., Ogasawara K., Uede T., and Onoé K. Defective development of NK1.1+ T-cell antigen receptor áâ+ cells in zeta-associated protein 70 null mice with an accumulation of NK1.1+ CD3- NK-like cells in the thymus. Blood 97 (2001) 1765-1775
21. Kalinski P., Hilkens C.M., Snijders A., Snijdewint F.G., and Kapsenberg M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159 (1997) 28-35
22. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
23. Kikuchi K., Yanagawa Y., Aranami T., Iwabuchi C., Iwabuchi K., and Onoé K. Tumour necrosis factor-α but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation. Immunology 108 (2003) 42-49
24. Kishida T., Asada H., Itokawa Y., Cui F.D., Shin-Ya M., Gojo S., Yasutomi K., Ueda Y., Yamagishi H., Imanishi J., and Mazda O. Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol. Ther. 8 (2003) 552-558
25. Leonard W.J., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5 (2005) 688-698
26. Ma H.L., Whitters M.J., Konz R.F., Senices M., Young D.A., Grusby M.J., Collins M., and Dunussi-Joannopoulos K. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-γ. J. Immunol. 171 (2003) 608-615
27. Madden K.B., Whitman L., Sullivan C., Gause W.C., Urban Jr. J.F., Katona I.M., Finkelman F.D., and Shea-Donohue T. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J. Immunol. 169 (2002) 4417-4422
28. Maeda M., Lohwasser S., Yamamura T., and Takei F. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 167 (2001) 4180-4186
29. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., and Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108 (2001) 1865-1873
30. Mehta D.S., Wurster A.L., and Grusby M.J. Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202 (2004) 84-95
31. Minami K., Yanagawa Y., Iwabuchi K., Shinohara N., Harabayashi T., Nonomura K., and Onoé K. Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions. Blood 106 (2005) 1685-1693
32. Miyamoto K., Miyake S., and Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531-534
33. Moroz A., Eppolito C., Li Q., Tao J., Clegg C.H., and Shrikant P.A. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J. Immunol. 173 (2004) 900-909
34. Rescigno M., Martino M., Sutherland C.L., Gold M.R., and Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188 (1998) 2175-2180
35. Rescigno M., Piguet V., Valzasina B., Lens S., Zubler R., French L., Kindler V., Tschopp J., and Ricciardi-Castagnoli P. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL) -1â, and the production of interferon ã in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192 (2000) 1661-1668
36. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2 (2001) 361-367
37. Schuurhuis D.H., Laban S., Toes R.E., Ricciardi-Castagnoli P., Kleijmeer M.J., van der Voort E.I., Rea D., Offringa R., Geuze H.J., Melief C.J., and Ossendorp F. Immature dendritic cells acquire CD8+ cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 192 (2000) 145-150
38. Shea-Donohue T., Sullivan C., Finkelman F.D., Madden K.B., Morris S.C., Goldhill J., Pineiro-Carrero V., and Urban Jr. J.F. The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J. Immunol. 167 (2001) 2234-2239
39. Singh N., Hong S., Scherer D.C., Serizawa I., Burdin N., Kronenberg M., Koezuka Y., and Kaer L.V. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163 (1999) 2373-2377
40. Smyth M.J., Cretney E., Takeda K., Wiltrout R.H., Sedger L.M., Kayagaki N., Yagita H., and Okumura K. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193 (2001) 661-670
41. Smyth M.J., Crowe N.Y., Pellicci D.G., Kyparissoudis K., Kelly J.M., Takeda K., Yagita H., and Godfrey D.I. Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99 (2002) 1259-1266
42. Smyth M.J., Wallace M.E., Nutt S.L., Yagita H., Godfrey D.I., and Hayakawa Y. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J. Exp. Med. 201 (2005) 1973-1985
43. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
44. Strait R.T., Morris S.C., Smiley K., Urban Jr. J.F., and Finkelman F.D. IL-4 exacerbates anaphylaxis. J. Immunol. 170 (2003) 3835-3842
45. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
46. Ugai S., Shimozato O., Kawamura K., Wang Y.Q., Yamaguchi T., Saisho H., Sakiyama S., and Tagawa M. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther. 10 (2003) 187-192
47. Villadangos J.A., Cardoso M., Steptoe R.J., van Berkel D., Pooley J., Carbone F.R., and Shortman K. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14 (2001) 739-749
48. Wang G., Tschoi M., Spolski R., Lou Y., Ozaki K., Feng C., Kim G., Leonard W.J., and Hwu P. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63 (2003) 9016-9022
49. Wilson M.T., Singh A.K., and Van Kaer L. Immunotherapy with ligands of natural killer T cells. Trends Mol. Med. 8 (2002) 225-231
50. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V.S., Davoust J., and Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185 (1997) 317-328
51. Wurster A.L., Rodgers V.L., Satoskar A.R., Whitters M.J., Young D.A., Collins M., and Grusby M.J. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med. 196 (2002) 969-977
52. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., and Steinman R.M. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235-247
53. Yanagawa Y., and Onoé K. CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100 (2002) 1948-1956
54. Yanagawa Y., and Onoé K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 101 (2003) 4923-4929
55. Yanagawa Y., and Onoé K. Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor κB-inducing kinase in mature dendritic cells. Immunology 117 (2006) 526-535
56. Yanagawa Y., Iijima N., Iwabuchi K., and Onoé K. Activation of extracellular signal-related kinase by TNF-α controls the maturation and function of murine dendritic cells. J. Leukoc. Biol. 71 (2002) 125-132
57. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., Pise-Masison C.A., Radonovich M.F., Brady J.N., Restifo N.P., Berzofsky J.A., and Leonard W.J. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201 (2005) 139-148